Skip to content

Immunity to liver-stage Plasmodium falciparum malaria parasites

Immunity to liver-stage Plasmodium falciparum in peripheral and tissue-resident immune cells

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN61332343
Enrollment
45
Registered
2022-11-07
Start date
2022-11-14
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimalarial immune response to liver-stage P. falciparum Infections and Infestations

Interventions

An observational study applying HLA-A2 phenotyping
isolation of hepatocytes and intrahepatic immune cells
expansion of a circumsporozoite protein (CSP)-specific CD8+ T cell line
antimalarial immune response to liver-stage P. falciparum 1. 6 ml blood will be drawn by venepuncture upon receipt of informed consent for HLA-A2 phenotyping 2. 24 ml blood will be drawn prior to liv

Sponsors

Radboud University Nijmegen Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and above 2. Scheduled for partial liver resection for underlying disease 3. Signed written informed consent

Exclusion criteria

Exclusion criteria: 1. Known receipt of immunosuppressive or cytostatic agents within the past 3 months, except the use of topical and inhaled steroids 2. Known human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis B virus (HBV) infection, or other known clinically-relevant immunodeficient state

Design outcomes

Primary

MeasureTime frame
Measured at the surgery visit: 1. Recognition of P. falciparum-infected hepatocytes by CSP-specific cytolytic CD8+ T cells and hepatic and peripheral innate/innate-like lymphocytes measured using flow cytometry 2. Killing of P. falciparum-infected hepatocytes by CSP-specific cytolytic CD8+ T cells and hepatic and peripheral innate/innate-like lymphocytes measured using fluorescence microscopy

Secondary

MeasureTime frame
Measured at the surgery visit: 1. Recognition and killing of P. falciparum-infected hepatocytes by CSP-specific cytolytic CD8+ T cell line measured using flow cytometry and fluorescence microscopy 2. Differences in recognition and killing of P. falciparum-infected hepatocytes between liver-resident and peripheral lymphocytes measured using flow cytometry and fluorescence microscopy 3. The individual lymphocyte (sub-)populations which contribute to the recognition and killing of P. falciparum-infected hepatocytes, identified using flow cytometry

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026